DEPO-PROVERA® CI Description
(medroxyprogesterone acetate injectable suspension, for intramuscular use)
11 DESCRIPTION
Depo-Provera CI contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off‑white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.
The chemical name for medroxyprogesterone acetate is pregn-4-ene-3, 20-dione, 17-(acetyloxy)-6-methyl-, (6α-).
The structural formula is as follows:
Depo-Provera CI for IM injection is available in vials and prefilled syringes, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.
For Depo-Provera CI vials, each mL of sterile aqueous suspension contains: | |
Medroxyprogesterone acetate | 150 mg |
Polyethylene glycol 3350 | 28.9 mg |
Polysorbate 80 | 2.41 mg |
Sodium chloride | 8.68 mg |
Methylparaben | 1.37 mg |
Propylparaben | 0.150 mg |
Water for injection | quantity sufficient |
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both. | |
For Depo-Provera CI prefilled syringes, each mL of sterile aqueous suspension contains: | |
Medroxyprogesterone acetate | 150 mg |
Polyethylene glycol 3350 | 28.5 mg |
Polysorbate 80 | 2.37 mg |
Sodium chloride | 8.56 mg |
Methylparaben | 1.35 mg |
Propylparaben | 0.147 mg |
Water for injection | quantity sufficient |
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both. | |
Find DEPO-PROVERA® CI medical information:
Find DEPO-PROVERA® CI medical information:
DEPO-PROVERA® CI Quick Finder
Health Professional Information
Description
11 DESCRIPTION
Depo-Provera CI contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off‑white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.
The chemical name for medroxyprogesterone acetate is pregn-4-ene-3, 20-dione, 17-(acetyloxy)-6-methyl-, (6α-).
The structural formula is as follows:
Depo-Provera CI for IM injection is available in vials and prefilled syringes, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.
For Depo-Provera CI vials, each mL of sterile aqueous suspension contains: | |
Medroxyprogesterone acetate | 150 mg |
Polyethylene glycol 3350 | 28.9 mg |
Polysorbate 80 | 2.41 mg |
Sodium chloride | 8.68 mg |
Methylparaben | 1.37 mg |
Propylparaben | 0.150 mg |
Water for injection | quantity sufficient |
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both. | |
For Depo-Provera CI prefilled syringes, each mL of sterile aqueous suspension contains: | |
Medroxyprogesterone acetate | 150 mg |
Polyethylene glycol 3350 | 28.5 mg |
Polysorbate 80 | 2.37 mg |
Sodium chloride | 8.56 mg |
Methylparaben | 1.35 mg |
Propylparaben | 0.147 mg |
Water for injection | quantity sufficient |
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both. | |
Health Professional Information
{{section_name_patient}}
{{section_body_html_patient}}
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.